Back to Search
Start Over
Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.
- Source :
-
British journal of pharmacology [Br J Pharmacol] 2012 Sep; Vol. 167 (2), pp. 407-20. - Publication Year :
- 2012
-
Abstract
- Background and Purpose: Here, we have compared the neurochemical profile of three new cathinones, butylone, mephedrone and methylone, in terms of their potential to inhibit plasmalemmal and vesicular monoamine transporters. Their interaction with 5-HT and dopamine receptors and their psychostimulant effect was also studied.<br />Experimental Approach: Locomotor activity was recorded in mice following different doses of cathinones. Monoamine uptake assays were performed in purified rat synaptosomes. Radioligand-binding assays were carried out to assess the affinity of these compounds for monoamine transporters or receptors.<br />Key Results: Butylone, mephedrone and methylone (5-25 mg·kg(-1) ) caused hyperlocomotion, which was prevented with ketanserin or haloperidol. Methylone was the most potent compound inhibiting both [(3) H]5-HT and [(3) H]dopamine uptake with IC(50) values that correlate with its affinity for dopamine and 5-HT transporter. Mephedrone was found to be the cathinone derivative with highest affinity for vesicular monoamine transporter-2 causing the inhibition of dopamine uptake. The affinity of cathinones for 5-HT(2A) receptors was similar to that of MDMA.<br />Conclusions and Implications: Butylone and methylone induced hyperlocomotion through activating 5-HT(2A) receptors and increasing extra-cellular dopamine. They inhibited 5-HT and dopamine uptake by competing with substrate. Methylone was the most potent 5-HT and dopamine uptake inhibitor and its effect partly persisted after withdrawal. Mephedrone-induced hyperlocomotion was dependent on endogenous 5-HT. Vesicular content played a key role in the effect of mephedrone, especially for 5-HT uptake inhibition. The potency of mephedrone in inhibiting noradrenaline uptake suggests a sympathetic effect of this cathinone.<br /> (© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.)
- Subjects :
- 3,4-Methylenedioxyamphetamine chemistry
3,4-Methylenedioxyamphetamine pharmacology
Animals
Brain drug effects
Brain metabolism
Carrier Proteins
Central Nervous System Stimulants chemistry
Central Nervous System Stimulants pharmacology
Dopamine metabolism
Dopamine Antagonists pharmacology
Dose-Response Relationship, Drug
Haloperidol pharmacology
Ketanserin pharmacology
Male
Methamphetamine chemistry
Methamphetamine pharmacokinetics
Methamphetamine pharmacology
Mice
Molecular Structure
Norepinephrine metabolism
Rats
Rats, Sprague-Dawley
Serotonin metabolism
Serotonin Antagonists pharmacology
Synaptosomes drug effects
3,4-Methylenedioxyamphetamine analogs & derivatives
Methamphetamine analogs & derivatives
Motor Activity drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5381
- Volume :
- 167
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- British journal of pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 22509960
- Full Text :
- https://doi.org/10.1111/j.1476-5381.2012.01998.x